This was accompanied by a relative increase in CD8+ effector memory cells and a decrease in CD8+ effector cells, indicating an increase in antigen-experienced (CD45RA−) CD8+ cells which is in line with what have been observed in multiple myeloma patients [43, 44]. The gene discussed is CD8A; the disease is plasma cell myeloma.